ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 Phase 3b LUCY Trial Subgroup Analysis: Clinical Effectiveness of Olaparib in BRCAm, HER2- mBC by ER Expression Level
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Karen Gelmon
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Karen Gelmon
Comments 0
Login to view comments.
Click here to Login